https://www.selleckchem.com/products/acbi1.html
6% (n= 6) of those whose only risk factor was age≥ 65 years, and 57.1% (n= 8) of those with both risk factors (P .001). BLI-induced mortality rates in each group were 0.0% (n= , 5.9% (n= 1), 10.5% (n= 2), and 42.9% (n= 6) (P .001), respectively. Among 31 patients with HTN, BLI incidence was 12.5% in patients who were administered RAAS inhibitors and 53.3% in those who were not (P= .02). Older age and history of HTN were independent risk factors for the development of BLI, and the administration of RAAS inhibitors might reduce th
Like
Comment
Share
